Dow Up0.26% Nasdaq Down1.07%

ImmunoCellular Therapeutics, Ltd. (IMUC)

-NYSE MKT
0.92 0.01(0.98%) Sep 15, 4:00PM EDT
|After Hours : 0.90 Down 0.01 (1.09%) Sep 15, 4:01PM EDT
Company EventsGet Company Events for:
Upcoming Events 
DateEvent
Nov 4 - Nov 10, 2014 (Est.)Earnings announcement
Recent Events 
DateEvent
2-Sep-14IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 8-K, Change in Directors or Principal Officers
8-Aug-14IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 10-Q, Quarterly Report
7-Aug-14IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statem
19-Jun-14IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
4-Jun-14IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 8-K, Regulation FD Disclosure, Other Events
9-May-14IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 10-Q, Quarterly Report
8-May-14IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statem
14-Mar-14IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 10-K, Annual Report
13-Mar-14IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statem
12-Mar-14IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
25-Feb-14IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
13-Jan-14IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
10-Jan-14IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
20-Dec-13IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 8-K, Change in Directors or Principal Officers
12-Dec-13IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
7-Nov-13IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 10-Q, Quarterly Report
6-Nov-13IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statem
24-Sep-13IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to Articl